Skip to main content

Advertisement

Table 1 Information on mesenchymal stem cells derived from ovarian cancer patients

From: Optimizing patient derived mesenchymal stem cells as virus carriers for a Phase I clinical trial in ovarian cancer

Sample ID Disease Process timing Grams of Fat Processed Karyotype (see footnote)
1 Newly Diagnosed Immediate 0.95 Normal
3 Newly Diagnosed Immediate 0.16 Abnormal1
4 Newly Diagnosed Immediate 2.26 Normal
7 Newly Diagnosed Immediate 3.96 Normal
8 Newly Diagnosed 43 hours 3.40 Normal
10 Newly Diagnosed Immediate 0.80 Normal
2 Relapsed 14 hours 2.23 Normal
5a Relapsed Immediate 1.50 Normal
5b Relapsed 20 hours 1.60 Abnormal2
6 Relapsed 11 hours 1.79 Normal
  1. 1Of 20 metaphases, 16 were normal and 4 had trisomy 20.
  2. 2Of 30 metaphases, 28 were normal and 2 had trisomy 20 and a balanced three-way translocation involving chromosomes 1, 10 and 13.
  3. Adipose tissues were either processed immediately or stored in the refrigerator at 4°C before collagenase digestion. Expanded MSC were karyotyped and two out of ten samples were found to have abnormal karyotype.